Citadel Advisors’s WebMD Health Corp. WBMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-82,900
Closed -$4.86M 8460
2017
Q2
$4.86M Buy
82,900
+69,200
+505% +$3.86M ﹤0.01% 2164
2017
Q1
$722K Sell
13,700
-4,500
-25% -$230K ﹤0.01% 4468
2016
Q4
$902K Buy
18,200
+3,700
+26% +$191K ﹤0.01% 3998
2016
Q3
$721K Buy
14,500
+400
+3% +$22.1K ﹤0.01% 4288
2016
Q2
$819K Sell
14,100
-6,600
-32% -$413K ﹤0.01% 3814
2016
Q1
$1.3M Sell
20,700
-22,000
-52% -$1.18M ﹤0.01% 3153
2015
Q4
$2.06M Buy
42,700
+1,500
+4% +$66.9K ﹤0.01% 2700
2015
Q3
$1.64M Buy
41,200
+8,700
+27% +$368K ﹤0.01% 3198
2015
Q2
$1.44M Sell
32,500
-4,300
-12% -$196K ﹤0.01% 3474
2015
Q1
$1.61M Buy
36,800
+8,000
+28% +$332K ﹤0.01% 3344
2014
Q4
$1.14M Buy
28,800
+15,800
+122% +$607K ﹤0.01% 3609
2014
Q3
$544K Buy
13,000
+200
+2% +$9.65K ﹤0.01% 4509
2014
Q2
$618K Buy
12,800
+8,500
+198% +$371K ﹤0.01% 4119
2014
Q1
$178K Sell
4,300
-12,400
-74% -$559K ﹤0.01% 5633
2013
Q4
$660K Buy
16,700
+4,900
+42% +$177K ﹤0.01% 3686
2013
Q3
$337K Buy
11,800
+1,800
+18% +$56.2K ﹤0.01% 4227
2013
Q2
$294K Buy
+10,000
New +$267K ﹤0.01% 4320

Other funds holding WBMD

Citadel Advisors's WBMD Position: Q3 2017 in Review

Citadel Advisors sold out of WebMD Health Corp. (WBMD) in Q3 2017, closing a stake of 504,713 shares — an estimated $29.6M sold.

Citadel Advisors first reported a position in WBMD in Q2 2013 and held it in 16 quarters. The position peaked at $47.5M in Q2 2014. 1 fund tracked by Wall St. Rank holds WBMD as of Q3 2017.

  • Citadel Advisors reported no remaining WebMD Health Corp. position as of Q3 2017 after selling out during the quarter.
  • Citadel Advisors sold 504,713 WebMD Health Corp. shares in Q3 2017, an estimated $29.6M.
  • Citadel Advisors first reported a position in WebMD Health Corp. in Q2 2013 and held it in 16 quarters.
  • Citadel Advisors's WebMD Health Corp. position peaked at $47.5M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held WebMD Health Corp. as of Q3 2017.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.